207 related articles for article (PubMed ID: 11198354)
21. Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.
Galve-de Rochemonteix B; Nicod LP; Dayer JM
Am J Respir Cell Mol Biol; 1996 Mar; 14(3):279-87. PubMed ID: 8845179
[TBL] [Abstract][Full Text] [Related]
22. Lipopolysaccharide-induced cytokine production and mortality in mice treated with Corynebacterium parvum.
Smith SR; Calzetta A; Bankowski J; Kenworthy-Bott L; Terminelli C
J Leukoc Biol; 1993 Jul; 54(1):23-9. PubMed ID: 8336076
[TBL] [Abstract][Full Text] [Related]
23. Combination immunotherapy with soluble tumor necrosis factor receptors plus interleukin 1 receptor antagonist decreases sepsis mortality.
Remick DG; Call DR; Ebong SJ; Newcomb DE; Nybom P; Nemzek JA; Bolgos GE
Crit Care Med; 2001 Mar; 29(3):473-81. PubMed ID: 11373406
[TBL] [Abstract][Full Text] [Related]
24. Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-2.
Cuesta N; Salkowski CA; Thomas KE; Vogel SN
J Immunol; 2003 Jun; 170(11):5739-47. PubMed ID: 12759457
[TBL] [Abstract][Full Text] [Related]
25. Differential sensitivity to Escherichia coli infection in mice lacking tumor necrosis factor p55 or interleukin-1 p80 receptors.
Acton RD; Dahlberg PS; Uknis ME; Klaerner HG; Fink GS; Norman JG; Dunn DL
Arch Surg; 1996 Nov; 131(11):1216-21. PubMed ID: 8911263
[TBL] [Abstract][Full Text] [Related]
26. Direct evidence for tumor necrosis factor-alpha signaling in arteriogenesis.
Hoefer IE; van Royen N; Rectenwald JE; Bray EJ; Abouhamze Z; Moldawer LL; Voskuil M; Piek JJ; Buschmann IR; Ozaki CK
Circulation; 2002 Apr; 105(14):1639-41. PubMed ID: 11940540
[TBL] [Abstract][Full Text] [Related]
27. O(2)-Vinyl 1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate protection against D-galactosamine/endotoxin-induced hepatotoxicity in mice: genomic analysis using microarrays.
Liu J; Saavedra JE; Lu T; Song JG; Clark J; Waalkes MP; Keefer LK
J Pharmacol Exp Ther; 2002 Jan; 300(1):18-25. PubMed ID: 11752092
[TBL] [Abstract][Full Text] [Related]
28. Role of LPS and receptor subtypes in the uptake of TNF by the murine lung.
Ortiz LA; Friedman M; Banks WA
Life Sci; 2001 Jul; 69(7):791-802. PubMed ID: 11487091
[TBL] [Abstract][Full Text] [Related]
29. Clinical clues to the cause of Addison's disease.
Vita JA; Silverberg SJ; Goland RS; Austin JH; Knowlton AI
Am J Med; 1985 Mar; 78(3):461-6. PubMed ID: 3976705
[TBL] [Abstract][Full Text] [Related]
30. Preconditioning up-regulates the soluble TNF receptor I response to endotoxin.
Wang M; Meng X; Tsai B; Wang JF; Turrentine M; Brown JW; Meldrum DR
J Surg Res; 2004 Sep; 121(1):20-4. PubMed ID: 15313370
[TBL] [Abstract][Full Text] [Related]
31. Enhanced tumor necrosis factor and interleukin-1 in an experimental model of massive liver cell necrosis/fatal hepatitis in mice.
Liu P; Ohnishi H; Moriwaki H; Muto Y
Gastroenterol Jpn; 1990 Jun; 25(3):339-42. PubMed ID: 2358165
[TBL] [Abstract][Full Text] [Related]
32. Addison's Disease: A Diagnostic Dilemma.
Afroz S; Bain S
Mymensingh Med J; 2017 Jul; 26(3):671-675. PubMed ID: 28919626
[TBL] [Abstract][Full Text] [Related]
33. ACTH suppression after oral administration of cortisone in Addisonian and adrenalectomized patients.
Aanderud S; Myking OL; Bassøe HH
Acta Endocrinol (Copenh); 1982 Aug; 100(4):588-94. PubMed ID: 6289586
[TBL] [Abstract][Full Text] [Related]
34. Bone mineral density in patients with treated Addison's disease.
Braatvedt GD; Joyce M; Evans M; Clearwater J; Reid IR
Osteoporos Int; 1999; 10(6):435-40. PubMed ID: 10663342
[TBL] [Abstract][Full Text] [Related]
35. Sexuality and fertility in women with Addison's disease.
Erichsen MM; Husebye ES; Michelsen TM; Dahl AA; Løvås K
J Clin Endocrinol Metab; 2010 Sep; 95(9):4354-60. PubMed ID: 20610594
[TBL] [Abstract][Full Text] [Related]
36. Hyporesponsiveness of donor cells to lipopolysaccharide stimulation reduces the severity of experimental idiopathic pneumonia syndrome: potential role for a gut-lung axis of inflammation.
Cooke KR; Hill GR; Gerbitz A; Kobzik L; Martin TR; Crawford JM; Brewer JP; Ferrara JL
J Immunol; 2000 Dec; 165(11):6612-9. PubMed ID: 11086106
[TBL] [Abstract][Full Text] [Related]
37. Contribution of TNF/TNF receptor and of Fas ligand to toxicity in murine models of endotoxemia and bacterial peritonitis.
Heumann D; Le Roy D; Zanetti G; Eugster HP; Ryffel B; Hahne M; Tschopp J; Glauser MP
J Inflamm; 1995-1996; 47(4):173-9. PubMed ID: 9144074
[TBL] [Abstract][Full Text] [Related]
38. Congenital adrenal hyperplasia with pseudohermaphrodism and symptoms of Addison's disease; clinical course following bilateral total adrenalectomy, with metabolic studies, pathologic findings and discussion of etiology.
LEWIS RA; KLEIN R; WILKINS L
J Clin Endocrinol Metab; 1950 Jul; 10(7):703-15. PubMed ID: 15436556
[No Abstract] [Full Text] [Related]
39. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.
Gérard C; Bruyns C; Marchant A; Abramowicz D; Vandenabeele P; Delvaux A; Fiers W; Goldman M; Velu T
J Exp Med; 1993 Feb; 177(2):547-50. PubMed ID: 8426124
[TBL] [Abstract][Full Text] [Related]
40. Hematologic interactions of endotoxin, tumor necrosis factor alpha (TNF alpha), interleukin 1, and adrenal hormones and the hematologic effects of TNF alpha in Corynebacterium parvum-primed rats.
Ulich TR; del Castillo J; Ni RX; Bikhazi N
J Leukoc Biol; 1989 Jun; 45(6):546-57. PubMed ID: 2786048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
